Market Cap 45.96B
Revenue (ttm) 6.07B
Net Income (ttm) 1.07B
EPS (ttm) N/A
PE Ratio 31.14
Forward PE 26.90
Profit Margin 17.69%
Debt to Equity Ratio 0.06
Volume 11,816,600
Avg Vol 4,965,944
Day's Range N/A - N/A
Shares Out 576.54M
Stochastic %K 92%
Beta 0.95
Analysts Strong Sell
Price Target $95.86

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provide...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 250 2500
Address:
One Edwards Way, Irvine, United States
Thelonius_Stonk
Thelonius_Stonk Apr. 25 at 11:04 AM
$EW looks good into next week
0 · Reply
XxGodFatherxX
XxGodFatherxX Apr. 24 at 1:44 PM
$EW 💩
0 · Reply
kcphaeton
kcphaeton Apr. 24 at 1:45 AM
$EW I made this comment back in October 2025. We really haven’t made a whole lot of progress but probably now that we have guidance in a positive manner. Maybe we can start climbing back to the all-time high which was around $130. Probably will take 12 to 18 months to get there. 
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 23 at 8:25 PM
$EW Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.66 up 8.20% YoY • Reported revenue of $1.65B up 16.70% YoY • Edwards Lifesciences is raising its full-year 2026 constant currency sales growth guidance to 9% to 11% and adjusted EPS guidance midpoint to $2.95-$3.05. The company projects Q2 2026 total sales between $1.66 and $1.74 billion.
0 · Reply
Estimize
Estimize Apr. 23 at 3:00 PM
$EW reports after the close, Estimize Consensus -0.01 EPS and +16.05M Revs compared to WS http://www.estimize.com/ew/fq1-2026?utm_content=p
0 · Reply
SparkyReturns
SparkyReturns Apr. 14 at 2:38 PM
$ICU I think they'll be fine with rolling out the SCD for AKI with Fresenius, but I hope they get another partner for the LVAD indication or another cytokine storm indication, that would be amazing. That's also a multi-Billion $ TAM. Someone like Medtronic, Edwards, Abbot, or Boston Scientific. GL longs! We are at the inflection point. $MDT $EW $ABT $BSX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 13 at 3:05 PM
$EW RSI: 32.25, MACD: -1.0030 Vol: 1.77, MA20: 81.18, MA50: 81.47 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
kcphaeton
kcphaeton Apr. 13 at 1:19 PM
$EW i’m not sure what you’re smoking. Some of us have been holding a long time to see it. Get back to its all-time high. The all-time high closing price for Edwards Lifesciences (EW) was $130.68, which occurred on December 30, 2021.
1 · Reply
Ndellomo
Ndellomo Apr. 3 at 11:00 AM
$EW Edwards is a "buy and hold forever" type of company - just make sure you're not paying "hold forever" prices. Wait for Mr. Market to have one of his mood swings and offer you a better deal. https://stratafinance.beehiiv.com/p/edwards-lifesciences
1 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Mar. 11 at 3:47 AM
$AORT strong EBITDA growth and niche structural heart portfolio…. M&A 8x premium multiple ~$78 a share price target? Call me crazy but could be possible $MDT $BSC $EW $JNJ
1 · Reply
Latest News on EW
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth

Apr 24, 2026, 12:50 PM EDT - 19 hours ago

Edwards Lifesciences Stock Surges On Heart Valve Devices Growth


Edwards Lifesciences Earnings Call Transcript: Q1 2026

Apr 23, 2026, 5:00 PM EDT - 1 day ago

Edwards Lifesciences Earnings Call Transcript: Q1 2026


Edwards Lifesciences Reports First Quarter Results

Apr 23, 2026, 4:15 PM EDT - 1 day ago

Edwards Lifesciences Reports First Quarter Results


Edwards Lifesciences Earnings Call Transcript: Q4 2025

Feb 10, 2026, 5:00 PM EST - 2 months ago

Edwards Lifesciences Earnings Call Transcript: Q4 2025


Edwards Lifesciences Reports Fourth Quarter Results

Feb 10, 2026, 4:15 PM EST - 2 months ago

Edwards Lifesciences Reports Fourth Quarter Results


Edwards Comments on JenaValve Acquisition

Jan 9, 2026, 6:48 PM EST - 3 months ago

Edwards Comments on JenaValve Acquisition


Edwards Lifesciences Transcript: Investor Day 2025

Dec 4, 2025, 8:30 AM EST - 5 months ago

Edwards Lifesciences Transcript: Investor Day 2025


Top small-cap plays for 2026

Nov 25, 2025, 1:24 PM EST - 5 months ago

Top small-cap plays for 2026

A COHR DG TXT VLO


Edwards Lifesciences Earnings Call Transcript: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 6 months ago

Edwards Lifesciences Earnings Call Transcript: Q3 2025


Edwards Lifesciences CFO Scott Ullem to step down by mid-2026

Oct 30, 2025, 4:38 PM EDT - 6 months ago

Edwards Lifesciences CFO Scott Ullem to step down by mid-2026


Edwards Lifesciences Announces CFO Transition Plan

Oct 30, 2025, 4:15 PM EDT - 6 months ago

Edwards Lifesciences Announces CFO Transition Plan


Edwards Lifesciences Reports Third Quarter Results

Oct 30, 2025, 4:13 PM EDT - 6 months ago

Edwards Lifesciences Reports Third Quarter Results


Edwards Lifesciences Transcript: Investor Update

Oct 27, 2025, 9:00 PM EDT - 6 months ago

Edwards Lifesciences Transcript: Investor Update


Edwards Lifesciences Earnings Call Transcript: Q2 2025

Jul 24, 2025, 5:00 PM EDT - 9 months ago

Edwards Lifesciences Earnings Call Transcript: Q2 2025


Edwards Lifesciences Reports Second Quarter Results

Jul 24, 2025, 4:15 PM EDT - 9 months ago

Edwards Lifesciences Reports Second Quarter Results


Trade Tracker: Bill Baruch buys Edwards Lifesciences

May 19, 2025, 2:13 PM EDT - 1 year ago

Trade Tracker: Bill Baruch buys Edwards Lifesciences


Edwards Lifesciences Earnings Call Transcript: Q1 2025

Apr 23, 2025, 5:00 PM EDT - 1 year ago

Edwards Lifesciences Earnings Call Transcript: Q1 2025


Edwards Lifesciences Earnings Call Transcript: Q4 2024

Feb 11, 2025, 5:00 PM EST - 1 year ago

Edwards Lifesciences Earnings Call Transcript: Q4 2024


Edwards Lifesciences Transcript: Investor Update

Oct 30, 2024, 2:00 PM EDT - 1 year ago

Edwards Lifesciences Transcript: Investor Update


Edwards Lifesciences Transcript: Investor Update

Oct 28, 2024, 4:00 PM EDT - 1 year ago

Edwards Lifesciences Transcript: Investor Update


Edwards Lifesciences Earnings Call Transcript: Q3 2024

Oct 24, 2024, 5:30 PM EDT - 1 year ago

Edwards Lifesciences Earnings Call Transcript: Q3 2024


Edwards Lifesciences Earnings Call Transcript: Q2 2024

Jul 24, 2024, 5:00 PM EDT - 1 year ago

Edwards Lifesciences Earnings Call Transcript: Q2 2024


Edwards Lifesciences Earnings Call Transcript: Q1 2024

Apr 25, 2024, 5:00 PM EDT - 2 years ago

Edwards Lifesciences Earnings Call Transcript: Q1 2024


Edwards Lifesciences Earnings Call Transcript: Q4 2023

Feb 6, 2024, 5:00 PM EST - 2 years ago

Edwards Lifesciences Earnings Call Transcript: Q4 2023


Edwards Lifesciences Transcript: Investor Update

Dec 7, 2023, 11:30 AM EST - 2 years ago

Edwards Lifesciences Transcript: Investor Update


Edwards Lifesciences Transcript: Investor Update

Oct 26, 2023, 5:30 PM EDT - 2 years ago

Edwards Lifesciences Transcript: Investor Update


Edwards Lifesciences Earnings Call Transcript: Q3 2023

Oct 25, 2023, 5:00 PM EDT - 2 years ago

Edwards Lifesciences Earnings Call Transcript: Q3 2023


Edwards Lifesciences Transcript: Status Update

Oct 24, 2023, 9:00 PM EDT - 2 years ago

Edwards Lifesciences Transcript: Status Update


Edwards Lifesciences Earnings Call Transcript: Q2 2023

Jul 26, 2023, 5:00 PM EDT - 2 years ago

Edwards Lifesciences Earnings Call Transcript: Q2 2023


Edwards Lifesciences Earnings Call Transcript: Q1 2023

Apr 26, 2023, 5:00 PM EDT - 3 years ago

Edwards Lifesciences Earnings Call Transcript: Q1 2023


Edwards Lifesciences Transcript: Cowen Health Care Conference

Mar 7, 2023, 10:30 AM EST - 3 years ago

Edwards Lifesciences Transcript: Cowen Health Care Conference


Edwards Lifesciences Earnings Call Transcript: Q4 2022

Jan 31, 2023, 5:00 PM EST - 3 years ago

Edwards Lifesciences Earnings Call Transcript: Q4 2022


Edwards Lifesciences Transcript: JPMorgan Healthcare Conference

Jan 10, 2023, 2:15 PM EST - 3 years ago

Edwards Lifesciences Transcript: JPMorgan Healthcare Conference


Edwards Lifesciences Transcript: Investor Day 2022

Dec 8, 2022, 6:00 AM EST - 3 years ago

Edwards Lifesciences Transcript: Investor Day 2022


Edwards Lifesciences Earnings Call Transcript: Q3 2022

Oct 27, 2022, 5:00 PM EDT - 3 years ago

Edwards Lifesciences Earnings Call Transcript: Q3 2022


Edwards Lifesciences Earnings Call Transcript: Q2 2022

Jul 27, 2022, 9:21 PM EDT - 4 years ago

Edwards Lifesciences Earnings Call Transcript: Q2 2022


Edwards Lifesciences Earnings Call Transcript: Q1 2022

Apr 26, 2022, 8:29 AM EDT - 4 years ago

Edwards Lifesciences Earnings Call Transcript: Q1 2022


Edwards Lifesciences Earnings Call Transcript: Q4 2021

Jan 26, 2022, 1:39 PM EST - 4 years ago

Edwards Lifesciences Earnings Call Transcript: Q4 2021


Edwards Lifesciences Transcript: Investor Day 2021

Dec 8, 2021, 11:30 AM EST - 4 years ago

Edwards Lifesciences Transcript: Investor Day 2021


Edwards Lifesciences Earnings Call Transcript: Q3 2021

Oct 26, 2021, 8:00 PM EDT - 4 years ago

Edwards Lifesciences Earnings Call Transcript: Q3 2021


Edwards Lifesciences Earnings Call Transcript: Q2 2021

Jul 28, 2021, 8:01 PM EDT - 5 years ago

Edwards Lifesciences Earnings Call Transcript: Q2 2021


Edwards Lifesciences Earnings Call Transcript: Q1 2021

Apr 20, 2021, 9:21 AM EDT - 5 years ago

Edwards Lifesciences Earnings Call Transcript: Q1 2021


Edwards Lifesciences Earnings Call Transcript: Q4 2020

Jan 27, 2021, 2:00 AM EST - 5 years ago

Edwards Lifesciences Earnings Call Transcript: Q4 2020


Edwards Lifesciences Transcript: Investor Day 2020

Dec 10, 2020, 12:00 PM EST - 5 years ago

Edwards Lifesciences Transcript: Investor Day 2020


Edwards Lifesciences Earnings Call Transcript: Q3 2020

Oct 21, 2020, 2:30 AM EDT - 5 years ago

Edwards Lifesciences Earnings Call Transcript: Q3 2020


Edwards Lifesciences Earnings Call Transcript: Q2 2020

Jul 23, 2020, 2:30 AM EDT - 6 years ago

Edwards Lifesciences Earnings Call Transcript: Q2 2020


Edwards Lifesciences Transcript: AGM 2020

May 7, 2020, 1:00 PM EDT - 6 years ago

Edwards Lifesciences Transcript: AGM 2020


Edwards Lifesciences Earnings Call Transcript: Q1 2020

Apr 23, 2020, 5:00 PM EDT - 6 years ago

Edwards Lifesciences Earnings Call Transcript: Q1 2020


Edwards Lifesciences Earnings Call Transcript: Q4 2019

Jan 30, 2020, 5:00 PM EST - 6 years ago

Edwards Lifesciences Earnings Call Transcript: Q4 2019


Edwards Lifesciences Transcript: Investor Day 2019

Dec 5, 2019, 8:30 AM EST - 6 years ago

Edwards Lifesciences Transcript: Investor Day 2019


Edwards Lifesciences Earnings Call Transcript: Q3 2019

Oct 23, 2019, 5:00 PM EDT - 7 years ago

Edwards Lifesciences Earnings Call Transcript: Q3 2019


Edwards Lifesciences Earnings Call Transcript: Q2 2019

Jul 23, 2019, 5:00 PM EDT - 7 years ago

Edwards Lifesciences Earnings Call Transcript: Q2 2019


Edwards Lifesciences Transcript: AGM 2019

May 8, 2019, 1:00 PM EDT - 7 years ago

Edwards Lifesciences Transcript: AGM 2019


Edwards Lifesciences Earnings Call Transcript: Q1 2019

Apr 23, 2019, 5:00 PM EDT - 7 years ago

Edwards Lifesciences Earnings Call Transcript: Q1 2019


Edwards Lifesciences Earnings Call Transcript: Q4 2018

Jan 31, 2019, 5:00 PM EST - 7 years ago

Edwards Lifesciences Earnings Call Transcript: Q4 2018


Edwards Lifesciences Transcript: Investor Day 2018 Part 2

Dec 5, 2018, 11:00 AM EST - 8 years ago

Edwards Lifesciences Transcript: Investor Day 2018 Part 2


Edwards Lifesciences Transcript: Investor Day 2018 Part 1

Dec 4, 2018, 7:00 PM EST - 8 years ago

Edwards Lifesciences Transcript: Investor Day 2018 Part 1


Edwards Lifesciences Earnings Call Transcript: Q3 2018

Oct 23, 2018, 5:00 PM EDT - 8 years ago

Edwards Lifesciences Earnings Call Transcript: Q3 2018


Edwards Lifesciences Earnings Call Transcript: Q2 2018

Jul 26, 2018, 5:00 PM EDT - 8 years ago

Edwards Lifesciences Earnings Call Transcript: Q2 2018


Edwards Lifesciences Transcript: AGM 2018

May 17, 2018, 1:00 PM EDT - 8 years ago

Edwards Lifesciences Transcript: AGM 2018


Edwards Lifesciences Earnings Call Transcript: Q1 2018

Apr 24, 2018, 5:00 PM EDT - 8 years ago

Edwards Lifesciences Earnings Call Transcript: Q1 2018


Thelonius_Stonk
Thelonius_Stonk Apr. 25 at 11:04 AM
$EW looks good into next week
0 · Reply
XxGodFatherxX
XxGodFatherxX Apr. 24 at 1:44 PM
$EW 💩
0 · Reply
kcphaeton
kcphaeton Apr. 24 at 1:45 AM
$EW I made this comment back in October 2025. We really haven’t made a whole lot of progress but probably now that we have guidance in a positive manner. Maybe we can start climbing back to the all-time high which was around $130. Probably will take 12 to 18 months to get there. 
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 23 at 8:25 PM
$EW Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.66 up 8.20% YoY • Reported revenue of $1.65B up 16.70% YoY • Edwards Lifesciences is raising its full-year 2026 constant currency sales growth guidance to 9% to 11% and adjusted EPS guidance midpoint to $2.95-$3.05. The company projects Q2 2026 total sales between $1.66 and $1.74 billion.
0 · Reply
Estimize
Estimize Apr. 23 at 3:00 PM
$EW reports after the close, Estimize Consensus -0.01 EPS and +16.05M Revs compared to WS http://www.estimize.com/ew/fq1-2026?utm_content=p
0 · Reply
SparkyReturns
SparkyReturns Apr. 14 at 2:38 PM
$ICU I think they'll be fine with rolling out the SCD for AKI with Fresenius, but I hope they get another partner for the LVAD indication or another cytokine storm indication, that would be amazing. That's also a multi-Billion $ TAM. Someone like Medtronic, Edwards, Abbot, or Boston Scientific. GL longs! We are at the inflection point. $MDT $EW $ABT $BSX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 13 at 3:05 PM
$EW RSI: 32.25, MACD: -1.0030 Vol: 1.77, MA20: 81.18, MA50: 81.47 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
kcphaeton
kcphaeton Apr. 13 at 1:19 PM
$EW i’m not sure what you’re smoking. Some of us have been holding a long time to see it. Get back to its all-time high. The all-time high closing price for Edwards Lifesciences (EW) was $130.68, which occurred on December 30, 2021.
1 · Reply
Ndellomo
Ndellomo Apr. 3 at 11:00 AM
$EW Edwards is a "buy and hold forever" type of company - just make sure you're not paying "hold forever" prices. Wait for Mr. Market to have one of his mood swings and offer you a better deal. https://stratafinance.beehiiv.com/p/edwards-lifesciences
1 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Mar. 11 at 3:47 AM
$AORT strong EBITDA growth and niche structural heart portfolio…. M&A 8x premium multiple ~$78 a share price target? Call me crazy but could be possible $MDT $BSC $EW $JNJ
1 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 2:57 PM
5 medical instrument stocks flashing serious short-term upside 👀 $ISRG $GMED $EW $ALC $IRMD are getting attention as AI tools, acquisitions, and new product pipelines fuel growth expectations — a combo that often sparks momentum in this space. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-teaser-36722&ADID=SYND_STOCKTWITS_TWEET_2_2881459_TEASER_36722
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 1:57 PM
Five medical instrument stocks with significant short-term potential! 🚀 🤖 $ISRG leads the charge with AI-driven innovations, boasting a Zacks Rank #1 and a short-term price target indicating a 26% increase from its last close, with an upside of up to 52%. 💼 $GMED strengthens its position with strategic mergers, a debt-free balance sheet, and a promising pipeline, marked by a Zacks Rank #1 and a short-term target of a 24.7% gain, with an upside of up to 40.1%. 💔 $EW is advancing its Structural Heart business, supported by a Zacks Rank #2 and a short-term price target increase of 14%, with a maximum upside of 30.5%. 👓 $ALC capitalizes on its Vision Care innovations, with a Zacks Rank #2 and a short-term target increase of 13.9%, with an upside of up to 36.8%. 🩺 $IRMD expands with MRI-compatible products, holding a Zacks Rank #2 and a forecasted 19.9% rise, with an upside of 20%. Explore the full growth story here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-body-36721&ADID=SYND_STOCKTWITS_TWEET_2_2881459_BODY_36721
0 · Reply
GettnFibbywIT
GettnFibbywIT Mar. 5 at 4:25 PM
$EW $XLV $IHI Kryptonite is to Superman as the $87 ish area has been to Edwards...
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Mar. 1 at 2:42 AM
$MASI trading at $175 with volume slightly above average, while $EW sitting at $86 with volume significantly above average. MASI showing more strength with a higher price level compared to EW. MedicalTech sector heating up, will one outshine the other in the long run?
0 · Reply
PaulLaurent
PaulLaurent Feb. 26 at 7:28 AM
🔥 Breakout Scanner (4) — February 26, 2026 NFA. Risk: use 1–2% capital per trade. $CNP – Trigger 43.19 | SL 34.55 | Scores: F50 V41 G76 Q38 VAL56 (stable). News (24h): no fresh company-specific headline spotted. $EW – Trigger 83.50 | SL 66.80 | Scores: F49 V38 G40 Q66 VAL52 (stable). News (24h): filed annual Form 10-K. $PM – Trigger 190.00 | SL 152.00 | Scores: F59 V52 G55 Q69 VAL41 (stable). News (24h): no fresh company-specific headline spotted. $VST – Trigger 177.00 | SL 141.60 | Scores: F44 V50 G23 Q54 VAL56 (stable). News (24h): no fresh company-specific headline spotted.
0 · Reply
fjsteven
fjsteven Feb. 17 at 4:54 PM
$EW this is moving today cause MDT released their six and seven year low risk data and it sucked.
1 · Reply
GettnFibbywIT
GettnFibbywIT Feb. 17 at 3:23 PM
$EW $XLV $IHI Edwards (EW) is rebounding off the lower boundary of its long‑term rising weekly channel. A weekly close back above the round‑number $80 level and the 7/21/25 weekly close — paired with RSI reclaiming the 50 line — would signal a constructive momentum shift. For traders who use structured credit spreads, a bull put spread placed a few months out with the short strike set below the 10/13/25 weekly low aligns with the underlying support structure and offers a defined‑risk way to potentially express an early bullish reversal thesis. This is not a recommendation to buy or sell, but rather a potential near‑term strategy idea that fits the current technical construct:
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 13 at 1:26 PM
$EW Share Price: $76.43 Contract Selected: Jun 18, 2026 $80 Calls Buy Zone: $3.47 – $4.29 Target Zone: $6.07 – $7.42 Potential Upside: 65% ROI Time to Expiration: 124 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
erevnon
erevnon Feb. 11 at 6:40 PM
Goldman Sachs maintains Edwards Lifesciences $EW at Buy and lowers the price target from $108 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
50bps
50bps Feb. 11 at 5:10 PM
$EW nice recovery
0 · Reply
ZacksResearch
ZacksResearch Feb. 11 at 1:26 PM
$EW misses on Q4 EPS but tops revenue estimates — a mixed bag for investors 🤔 - Q4 EPS of 58 cents missed the Zacks Consensus Estimate by 5.89% 📉 - Q4 sales rose 13.3% YoY to $1.57B, beating estimates by 1.99% 🚀 - TAVR segment saw a 12% sales increase, reflecting strong demand Discover the full earnings breakdown here 👉 https://www.zacks.com/stock/news/2853826/ews-q4-earnings-miss-estimates-revenues-up-yy-stock-climbs?cid=sm-stocktwits-2-2853826-body-32973&ADID=SYND_STOCKTWITS_TWEET_2_2853826_BODY_32973
0 · Reply
ZacksResearch
ZacksResearch Feb. 11 at 12:26 PM
$EW earnings miss… and the stock still climbs? 👀 Q4 earnings came in below estimates, but revenues were up year over year — and the market is clearly focusing on the growth, not the miss. When a stock rallies on an earnings miss, that tells you sentiment and forward expectations may be stronger than the headline suggests. Is this strength sustainable or just a short-term pop? Full breakdown here 👉 https://www.zacks.com/stock/news/2853826/ews-q4-earnings-miss-estimates-revenues-up-yy-stock-climbs?cid=sm-stocktwits-2-2853826-teaser-32968&ADID=SYND_STOCKTWITS_TWEET_2_2853826_TEASER_32968
0 · Reply